What is CGEM's dilution risk score?

CGEM has a latest available DilutionScore record of 32/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CGEM, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CGEM?

DilutionWatch tracks 25 SEC filing types for CGEM including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CGEM shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CGEM, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CGEM tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CGEM. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CGEM Dilution Risk Score: 32/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

25

📊 Float Risk

35

⚠️ Warrant Exposure

40

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for CGEM.

🔔 Track CGEM — Get forecast alerts →

Market Data

Market Cap$1.01B

Shares Outstanding64.35M

Float44.27M

Cash$334.54M

Debt$2.38M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.7% shares (2026Q1 vs prior)

174 institutional holders · 71.93M shares

#1 Lynx1 Capital Management LP 8.96M shares

#2 MPM BIOIMPACT LLC 7.65M shares

#3 BVF INC/IL 5.75M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.25M

Days to Cover19.2

% of Float23.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-09-30

4 INSIDER TRANSACTION 2026-03-09

4 INSIDER TRANSACTION 2026-02-26

4 INSIDER TRANSACTION 2026-02-25

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CGEM Dilution Snapshot

Cullinan Therapeutics, Inc. (CGEM) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for CGEM: 4 on 2026-03-09; 4 on 2026-02-26; 4 on 2026-02-25.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.